Article
Clinical implication of p53 mutation in lung cancer.
Molecular biotechnology - 1 Jun 2003
Campling Barbara G, El-Deiry Wafik S
Abstract excerpt
Lung cancer development involves multiple genetic abnormalities leading to malignant transformation of the bronchial epithelial cells, followed by invasion and metastasis. One of the most common changes is mutation of the p53 tumor suppressor gene. The frequency of p53 alterations in lung cancer is highest in small cell and squamous cell carcinomas. A genetic "signature" of the type of p53 mutations has been...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
